Hu Yang, Ma Shanshan, Yang Zhuohong, Zhou Wuyi, Du Zhengshan, Huang Jian, Yi Huan, Wang Chaoyang
Research Institute of Materials Science, South China University of Technology, Guangzhou 510640, China; Institute of Biomaterials, College of Materials and Energy, South China Agriculture University, Guangzhou 510642, China.
Research Institute of Materials Science, South China University of Technology, Guangzhou 510640, China.
Colloids Surf B Biointerfaces. 2016 Apr 1;140:382-391. doi: 10.1016/j.colsurfb.2016.01.005. Epub 2016 Jan 6.
In this study, we develop a facile one-pot approach to the fabrication of poly(L-lactic acid) (PLLA) microsphere-incorporated calcium alginate (ALG-Ca)/hydroxyapatite (HAp) porous scaffolds based on HAp nanoparticle-stabilized oil-in-water Pickering emulsion templates, which contain alginate in the aqueous phase and PLLA in the oil phase. The emulsion aqueous phase is solidified by in situ gelation of alginate with Ca(2+) released from HAp by decreasing pH with slow hydrolysis of D-gluconic acid δ-lactone (GDL) to produce emulsion droplet-incorporated gels, followed by freeze-drying to form porous scaffolds containing microspheres. The pore structure of porous scaffolds can be adjusted by varying the HAp or GDL concentration. The compressive tests show that the increase of HAp or GDL concentration is beneficial to improve the compressive property of porous scaffolds, while the excessive HAp can lead to the decrease in compressive property. Moreover, the swelling behavior studies display that the swelling ratios of porous scaffolds reduce with increasing HAp or GDL concentration. Furthermore, hydrophobic drug ibuprofen (IBU) and hydrophilic drug bovine serum albumin (BSA) are loaded into the microspheres and scaffold matrix, respectively. In vitro drug release results indicate that BSA has a rapid release while IBU has a sustained release in the dual drug-loaded scaffolds. In vitro cell culture experiments verify that mouse bone mesenchymal stem cells can proliferate on the porous scaffolds well, indicating the good biocompatibility of porous scaffolds. All these results demonstrate that the PLLA microsphere-incorporated ALG-Ca/HAp porous scaffolds have a promising potential for tissue engineering and drug delivery applications.
在本研究中,我们基于羟基磷灰石(HAp)纳米颗粒稳定的水包油型Pickering乳液模板,开发了一种简便的一锅法来制备聚(L-乳酸)(PLLA)微球复合海藻酸钙(ALG-Ca)/羟基磷灰石(HAp)多孔支架,该模板的水相中含有海藻酸盐,油相中含有PLLA。乳液水相通过海藻酸盐与HAp释放的Ca(2+)原位凝胶化而固化,通过D-葡萄糖酸δ-内酯(GDL)的缓慢水解降低pH值来实现,从而产生包含乳液液滴的凝胶,随后冷冻干燥形成含有微球的多孔支架。多孔支架的孔结构可以通过改变HAp或GDL的浓度来调节。压缩试验表明,HAp或GDL浓度的增加有利于提高多孔支架的压缩性能,而过量的HAp会导致压缩性能下降。此外,溶胀行为研究表明,多孔支架的溶胀率随着HAp或GDL浓度的增加而降低。此外,疏水性药物布洛芬(IBU)和亲水性药物牛血清白蛋白(BSA)分别被负载到微球和支架基质中。体外药物释放结果表明,在双载药支架中,BSA具有快速释放,而IBU具有缓释效果。体外细胞培养实验证实,小鼠骨髓间充质干细胞能够在多孔支架上良好地增殖,表明多孔支架具有良好的生物相容性。所有这些结果表明,PLLA微球复合ALG-Ca/HAp多孔支架在组织工程和药物递送应用方面具有广阔的前景。